OliLux Biosciences Kickstarts a Partnership With the UCSF Center
OliLux Biosciences is partnering with the R2D2 TB Network and the UCSF Center for Tuberculosis to clinically evaluate and advance its novel rapid detection technology for drug-resistant tuberculosis.